2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
Treatment of Venous Thromboembolism in Cancer Patients
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Rivaroxaban
3
Heparin, Low-Molecular-Weight
3
acarboxyprothrombin
1
N(4)-oleylcytosine arabinoside
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Treatment of Venous Thromboembolism in Cancer Patients
×
N(4)-oleylcytosine arabinoside
×
Clear all
NCT04979780
2024-10-31
OSCAR-US
Bayer
Completed
3,708 enrolled